Hims & Hers Reports 49% Revenue Growth in Q3 2026 Amid International Expansion
Hims & Hers Health, Inc. (HIMS) reported strong third-quarter results for 2026, with revenue reaching $890.4 million, a 49% increase year-over-year. Growth was heavily driven by international markets, where revenue surged 321% following the acquisition of Eucalyptus. Despite this top-line success, the company reported a net loss of $33.0 million compared to a profit in the prior year, and gross margins declined to 57% due to a higher mix of branded weight loss products. Management is currently navigating strategic shifts, including brand consolidation in international markets and moderated marketing spend within the U.S. weight loss specialty. While these moves led to a sequential decrease of 100,000 subscribers, leadership indicated that these decisions prioritize long-term platform strength over near-term subscriber counts. The company has tightened its full-year revenue guidance while reducing adjusted EBITDA projections to account for aggressive marketing and strategic pricing in Europe.
Tickers: $HIMS
Topics: Acquisition Impact EBITDA Financial Guidance Revenue Growth Subscriber Metrics
Read the full article at Motley Fool
Part of the story Boyd Group Services Reports 28.2% Revenue Growth in Third Quarter 2026 (23 articles)